Veeva Systems Inc. (veev)
VEEV — Company Overview
Veeva Systems Inc. (VEEV) is a large-cap company in the Healthcare sector, operating in Health Information Services.
| Ticker | VEEV |
| Sector | Healthcare |
| Industry | Health Information Services |
| Exchange | NYQ |
| Market cap | $43.84B |
| Last price | $270.75 |
| Size category | Large Cap |
VEEV — Business Description
Veeva Systems Inc. (VEEV) operates in Health Information Services within the broader Healthcare market. Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longi…
Official website: https://www.veeva.com.
VEEV — Investment Thesis
The investment thesis for Veeva Systems Inc. (VEEV) rests on how Healthcare dynamics, profitability, and valuation interact at today's price.
- Revenue is expanding at roughly 17.6% year-over-year (public data).
- Trailing P/E of 42.71× implies elevated growth expectations at the current price.
- Forward P/E (26.41×) is below trailing P/E — earnings may be expected to improve.
- Equity market capitalization is approximately $43.84B.
See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.
VEEV — Financial Health
Financial health for Veeva Systems Inc. (VEEV) is summarized from publicly reported profitability, leverage, and cash-flow metrics.
Profit margin of 29.3% indicates solid bottom-line conversion. Positive free cash flow of $1.26B supports balance-sheet flexibility.
| Trailing P/E | 42.71× |
| Forward P/E | 26.41× |
| Price / Sales | 12.68× |
| Price / Book | 6.04× |
| Gross margin | 75.0% |
| Operating margin | 29.6% |
| Profit margin | 29.3% |
| Return on equity | 14.4% |
| Debt / Equity | 2.04 |
| Free cash flow | $1.26B |
VEEV — Growth Outlook
Growth outlook for Veeva Systems Inc. (VEEV) depends on demand trends in Health Information Services and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 17.6% indicates strong top-line momentum.
- Earnings growth of 39.5% year-over-year supports improving profitability.
- Price is 12.8% below the 52-week high.
VEEV — Competitive Position
Veeva Systems Inc. (VEEV) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Health Information Services.
- Market capitalization of $43.84B places VEEV among large-cap peers.
- Gross margin near 75.0% may reflect pricing power or favorable mix.
VEEV — Strengths
Strengths for Veeva Systems Inc. (VEEV) inferred from public financial metrics:
- Revenue growth of 17.6% year-over-year.
- Earnings growth of 39.5% year-over-year.
- Gross margin of 75.0% supports competitive unit economics.
- Positive free cash flow ($1.26B).
- Moderate leverage (debt/equity 2.04).
- Large Cap scale ($43.84B) may provide distribution and funding advantages.
VEEV — Weaknesses
Weaknesses and pressure points for Veeva Systems Inc. (VEEV) based on available data:
- Elevated trailing P/E (42.71×) limits valuation margin of safety.
VEEV — Opportunities
- Sustained revenue growth (17.6%) could support multiple expansion if margins hold.
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
VEEV — Risks
- Rich valuation (P/E 42.71×) increases downside if growth slows.
VEEV — Summary
Veeva Systems Inc. (VEEV) is a large-cap Healthcare company focused on Health Information Services, listed on NYQ. Last price $270.75 with market cap $43.84B. Trailing P/E 42.71×. Revenue grew 17.6% year-over-year per public data. Notable strengths include revenue growth of 17.6% year-over-year. Key watch items include elevated trailing p/e (42.71×) limits valuation margin of safety. Public estimates and earnings snapshots for Veeva Systems Inc. are on this site; ownership, live news, and deeper models remain in Vest Terminal.
Start Free — open VEEV in Vest Terminal
Access live data, filings, ownership, and analysis for Veeva Systems Inc..
Veeva Systems Inc. FAQ
What does Veeva Systems Inc. (VEEV) do?
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology…
What is VEEV's P/E ratio?
Veeva Systems Inc. has a trailing P/E of 42.71× based on publicly available market data.
Does VEEV pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is VEEV in?
Veeva Systems Inc. is classified in Healthcare (Health Information Services) on NYQ.
What is VEEV's market capitalization?
Approximate market cap: $43.84B.
What are the main risks for VEEV?
Key risks include elevated valuation, among factors on this page.
What are the strengths of VEEV?
Potential positives include revenue growth of 17.6% year-over-year, earnings growth of 39.5% year-over-year.
Where can I get analyst estimates for VEEV?
Public analyst price targets and consensus for Veeva Systems Inc. are on the free /stocks/veev/estimates page. Deeper estimate history and models are available in Vest Terminal.